Quinolines derivatives as novel anticancer agents
US10179770B2 · kind B2 · utility
0Cited by
2References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2014 |
| Grant date | Jan 15, 2019 |
| Priority date | — |
| Expiry date | Mar 1, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/113
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides quinoline derivatives, their manufacture, pharmaceutical compositions containing them, and their use as medicaments. The active compounds of the present invention are useful for the treatment of proliferative neoplastic and non-neoplastic diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.